Ritonavir
Back to searchMolecule Structure
Scientific Name
Ritonavir
Description of the Drug
Ritonavir is an HIV protease inhibitor used in combination with other antivirals in the treatment of HIV infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00503
http://www.drugbank.ca/drugs/DB00503
Brand Name(s)
Norvir, Ritonavir
Company Owner(s)
Cipla Ltd, Laurus Labs Ltd, Abbott Laboratories Pharmaceutical Products Div, Hetero Labs Ltd Unit Iii, Aurobindo Pharma Ltd, Abbvie Inc, Lannett Co Inc, Amneal Pharmaceuticals Llc, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cytochrome P450 3A | PROTEIN FAMILY | INHIBITOR | CHEMBL2364675 |
| Human immunodeficiency virus type 1 protease | SINGLE PROTEIN | INHIBITOR | CHEMBL243 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL6679 | |||||
| PharmGKB | PA451260 | |||||
| Human Metabolome Database | HMDB0014646 | |||||
| DrugBank | DB00503 | |||||
| PubChem: Thomson Pharma | 14766505 | 14790837 | ||||
| PubChem | 392622 | |||||
| Mcule | MCULE-9029064305 | |||||
| LINCS | LSM-5623 | |||||
| Nikkaji | J659.314C | |||||
| PDBe | RIT | |||||
| BindingDB | 50088504 | 520 | ||||
| EPA CompTox Dashboard | DTXSID1048627 | |||||
| DrugCentral | 2391 | |||||
| Brenda | 52305 | 60913 | 133918 | 160172 | 33326 | 134732 |
| ChemicalBook | CB0119429 | |||||
| Guide to Pharmacology | 8804 | |||||
| rxnorm | RITONAVIR | NORVIR | ||||
| PubChem: Drugs of the Future | 12014859 | |||||
| KEGG Ligand | C07240 | |||||
| ChEBI | 45409 | |||||
| ZINC | ZINC000003944422 |
